Clinical Trial Update: Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tivozanib plus nivolumab to tivozanib alone in renal cell carcinoma; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Tivozanib (tivozanib)
• nivolumab (nivolumab)

Snippet

Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Renal Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING